Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. V. Misyurin
Expression Levels of the Apoptosis Genes FAS, TNFR2, TRAIL, DR3 and DR4/5 in Patients With Newly Diagnosed Chronic Lymphatic Leukemia Before and After Treatment With Fludarabine, Cyclophosphamide and Rituximab (FCR)
Almanac of Clinical Medicine
Related publications
Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine
Cancer Management and Research
Oncology
The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies
Therapeutic Advances in Hematology
Hematology
Fludarabine Plus Cyclophosphamide and Rituximab in Waldenstrom Macroglobulinemia
Cancer
Cancer Research
Oncology
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prognostic Role of CD4 T-Cell Depletion After Frontline Fludarabine, Cyclophosphamide and Rituximab in Chronic Lymphocytic Leukaemia
BMC Cancer
Cancer Research
Oncology
Genetics
Chronic Hepatitis E in Patients With Indolent Lymphoma After Treatment With Rituximab and Bendamustine
Hepatology
Medicine
Hepatology
The Condition of Homeostatic Equilibrium in Patients With Newly Diagnosed Pulmonary Tuberculosis Before Treatment
The Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University
Rituximab–cyclophosphamide–dexamethasone Combination in the Management of Autoimmune Cytopenias Associated With Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
